Blue Chip Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$446K Buy
1,756
+64
+4% +$15.9K 0.35% 62
2020
Q2
$399K Buy
1,692
+12
+0.7% +$2.74K 0.38% 63
2020
Q1
$341K Buy
1,680
+376
+29% +$82.1K 0.42% 58
2019
Q4
$314K Sell
1,304
-175
-12% -$38.6K 0.29% 76
2019
Q3
$286K Sell
1,479
-75
-5% -$14.4K 0.3% 74
2019
Q2
$286K Sell
1,554
-14
-0.9% -$2.51K 0.3% 75
2019
Q1
$298K Sell
1,568
-225
-13% -$43K 0.34% 69
2018
Q4
$349K Buy
1,793
+75
+4% +$14.6K 0.46% 59
2018
Q3
$356K Buy
1,718
+110
+7% +$21.7K 0.36% 65
2018
Q2
$297K Sell
1,608
-50
-3% -$8.84K 0.32% 78
2018
Q1
$283K Buy
+1,658
New +$304K 0.29% 77

Other funds holding AMGN

Blue Chip Wealth Management's AMGN Position: Q3 2020 in Review

Blue Chip Wealth Management increased its Amgen (AMGN) stake by 3.8% in Q3 2020, buying an estimated $15.9K and bringing the position to 1,756 shares worth $446K. The position accounts for 0.35% of the portfolio, ranked #62.

Blue Chip Wealth Management first reported a position in AMGN in Q1 2018 and has held it in 11 quarters since. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Blue Chip Wealth Management held 1,756 shares of Amgen worth $446K as of Q3 2020.
  • Blue Chip Wealth Management bought 64 Amgen shares in Q3 2020, an estimated $15.9K.
  • Amgen made up 0.35% of Blue Chip Wealth Management's portfolio in Q3 2020, its #62 holding.
  • Blue Chip Wealth Management first reported a position in Amgen in Q1 2018 and has held it in 11 quarters since.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Blue Chip Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.